Henrik Winther

Title: Henrik Winther: Innovator in Monoclonal Antibody Development

Introduction

Henrik Winther is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for both diagnostic and therapeutic applications in medicine.

Latest Patents

Henrik Winther holds a patent for the PAX 5 monoclonal antibody. This invention relates to anti-human PAX 5 antibodies that can bind to specific epitopes within the C-terminal regulatory domain of PAX 5. The patent details an antibody, antigen binding fragment, or recombinant protein capable of specific binding to an epitope located within the C-terminal fragment of the human PAX 5 protein. The epitope comprises a sequence of amino acids, specifically GSPYYYSAAARGAAPPA (SEQ ID NO:2). The invention also includes immunogenic peptide sequences for the production of these antibodies, along with their diagnostic and therapeutic applications.

Career Highlights

Henrik Winther is associated with Dako Denmark A/S, a company known for its advancements in diagnostic solutions. His work at Dako has allowed him to focus on innovative approaches to antibody development, contributing to the company's reputation in the biotechnology sector.

Collaborations

Henrik has collaborated with notable colleagues such as Kurt Pii and Jakob O Gjørret. These collaborations have fostered a productive environment for research and development in monoclonal antibody technology.

Conclusion

Henrik Winther's contributions to the field of monoclonal antibodies exemplify the impact of innovation in biotechnology. His patent for the PAX 5 monoclonal antibody highlights the potential for advancements in medical diagnostics and therapeutics.